Medix Biochemica develops, produces, and markets monoclonal antibodies, antibody services and recombinant antigens for IVD industry as well as POC tests for human healthcare.

Medix Biochemica has over 30 years’ experience in providing high quality raw materials and diagnostic tests to the IVD market. Medix Biochemica operates in two locations in Finland and employs nearly 100 highly educated people. Medix Biochemica established an affiliate in China in 2016.

The company has an extensive knowledge base in in vitro immunodiagnostics and devotes a substantial part of its revenue to R&D.  Its operations are ISO 9001 and ISO 13485 certified and conform to FDA QSR requirements.


MedixMAB™ Antibodies and MedixAntigens™ product lines include monoclonal antibodies and recombinant antigens. Products are targeted  for multiple diagnostic fields and applications, such as cardiovascular diseases, cell surface proteins, diabetes and metabolism, hormones, infectious diseases, inflammation, serology, thyroid function, and tumor diagnostics. In addition, Medix Biochemica offers flexible and customized services for diagnostic industry.

Actim® rapid tests are easy to use bedside tests for pregnancy monitoring (detection of membrane rupture and screening for risk of preterm delivery), immunological FOB testing, screening of acute Pancreatitis and acute disease testing (CRP, Influenza A&B, RSV, Noro).

Contact information



Related posts